Literature DB >> 24760294

Analysis of the lipidome of xenografts using MALDI-IMS and UHPLC-ESI-QTOF.

Roberto Fernández1, Sergio Lage, Beatriz Abad-García, Gwendolyn Barceló-Coblijn, Silvia Terés, Daniel H López, Francisca Guardiola-Serrano, M Laura Martín, Pablo V Escribá, José A Fernández.   

Abstract

Human tumor xenografts in immunodeficient mice are a very popular model to study the development of cancer and to test new drug candidates. Among the parameters analyzed are the variations in the lipid composition, as they are good indicators of changes in the cellular metabolism. Here, we present a study on the distribution of lipids in xenografts of NCI-H1975 human lung cancer cells, using MALDI imaging mass spectrometry and UHPLC-ESI-QTOF. The identification of lipids directly from the tissue by MALDI was aided by the comparison with identification using ESI ionization in lipid extracts from the same xenografts. Lipids belonging to PCs, PIs, SMs, DAG, TAG, PS, PA, and PG classes were identified and their distribution over the xenograft was determined. Three areas were identified in the xenograft, corresponding to cells in different metabolic stages and to a layer of adipose tissue that covers the xenograft.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24760294     DOI: 10.1007/s13361-014-0882-3

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  80 in total

1.  Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues.

Authors:  M Stoeckli; P Chaurand; D E Hallahan; R M Caprioli
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

2.  Matrix sublimation/recrystallization for imaging proteins by mass spectrometry at high spatial resolution.

Authors:  Junhai Yang; Richard M Caprioli
Journal:  Anal Chem       Date:  2011-06-28       Impact factor: 6.986

3.  MALDI mass spectrometric imaging of lipids in rat brain injury models.

Authors:  Joseph A Hankin; Santiago E Farias; Robert M Barkley; Kim Heidenreich; Lauren C Frey; Kei Hamazaki; Hee-Yong Kim; Robert C Murphy
Journal:  J Am Soc Mass Spectrom       Date:  2011-04-09       Impact factor: 3.109

4.  Sublimation as a method of matrix application for mass spectrometric imaging.

Authors:  Joseph A Hankin; Robert M Barkley; Robert C Murphy
Journal:  J Am Soc Mass Spectrom       Date:  2007-06-30       Impact factor: 3.109

5.  Desorption electrospray ionization mass spectrometry: Imaging drugs and metabolites in tissues.

Authors:  Justin M Wiseman; Demian R Ifa; Yongxin Zhu; Candice B Kissinger; Nicholas E Manicke; Peter T Kissinger; R Graham Cooks
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

6.  On-tissue protein identification and imaging by MALDI-ion mobility mass spectrometry.

Authors:  Jonathan Stauber; Luke MacAleese; Julien Franck; Emmanuelle Claude; Marten Snel; Basak Kükrer Kaletas; Ingrid M V D Wiel; Maxence Wisztorski; Isabelle Fournier; Ron M A Heeren
Journal:  J Am Soc Mass Spectrom       Date:  2009-09-29       Impact factor: 3.109

7.  Semi-quantitative analyses of metabolic systems of human colon cancer metastatic xenografts in livers of superimmunodeficient NOG mice.

Authors:  Akiko Kubo; Mitsuyo Ohmura; Masatoshi Wakui; Takahiro Harada; Shigeki Kajihara; Kiyoshi Ogawa; Hiroshi Suemizu; Masato Nakamura; Mitsutoshi Setou; Makoto Suematsu
Journal:  Anal Bioanal Chem       Date:  2011-04-10       Impact factor: 4.142

8.  Organ-specific distributions of lysophosphatidylcholine and triacylglycerol in mouse embryo.

Authors:  Takahiro Hayasaka; Naoko Goto-Inoue; Nobuhiro Zaima; Yoshishige Kimura; Mitsutoshi Setou
Journal:  Lipids       Date:  2009-08-15       Impact factor: 1.880

9.  Molecular imaging of proteins in tissues by mass spectrometry.

Authors:  Erin H Seeley; Richard M Caprioli
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-05       Impact factor: 11.205

10.  Sphingomyelin/phosphatidylcholine and cholesterol interactions studied by imaging mass spectrometry.

Authors:  Leiliang Zheng; Carolyn M McQuaw; Andrew G Ewing; Nicholas Winograd
Journal:  J Am Chem Soc       Date:  2007-11-29       Impact factor: 15.419

View more
  6 in total

1.  Identification of Biomarkers of Necrosis in Xenografts Using Imaging Mass Spectrometry.

Authors:  Roberto Fernández; Jone Garate; Sergio Lage; Silvia Terés; Mónica Higuera; Joan Bestard-Escalas; Daniel H López; Francisca Guardiola-Serrano; Pablo V Escribá; Gwendolyn Barceló-Coblijn; José A Fernández
Journal:  J Am Soc Mass Spectrom       Date:  2015-09-25       Impact factor: 3.109

Review 2.  Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer.

Authors:  Matthias Holzlechner; Eliseo Eugenin; Brendan Prideaux
Journal:  Cancer Rep (Hoboken)       Date:  2019-12

Review 3.  Applications of mass spectrometry for cellular lipid analysis.

Authors:  Chunyan Wang; Miao Wang; Xianlin Han
Journal:  Mol Biosyst       Date:  2015-01-19

4.  Optimized Protocol To Analyze Changes in the Lipidome of Xenografts after Treatment with 2-Hydroxyoleic Acid.

Authors:  Roberto Fernández; Jone Garate; Sergio Lage; Silvia Terés; Mónica Higuera; Joan Bestard-Escalas; M Laura Martin; Daniel H López; Francisca Guardiola-Serrano; Pablo V Escribá; Gwendolyn Barceló-Coblijn; José A Fernández
Journal:  Anal Chem       Date:  2015-12-15       Impact factor: 6.986

5.  Minerval (2-hydroxyoleic acid) causes cancer cell selective toxicity by uncoupling oxidative phosphorylation and compromising bioenergetic compensation capacity.

Authors:  Wessal Massalha; Mark Markovits; Edward Pichinuk; Yael Feinstein-Rotkopf; Mark Tarshish; Kumudesh Mishra; Victoria Llado; Miguel Weil; Pablo V Escriba; Or Kakhlon
Journal:  Biosci Rep       Date:  2019-01-18       Impact factor: 3.840

6.  A Drastic Shift in Lipid Adducts in Colon Cancer Detected by MALDI-IMS Exposes Alterations in Specific K+ Channels.

Authors:  Jone Garate; Albert Maimó-Barceló; Joan Bestard-Escalas; Roberto Fernández; Karim Pérez-Romero; Marco A Martínez; Mª Antònia Payeras; Daniel H Lopez; José Andrés Fernández; Gwendolyn Barceló-Coblijn
Journal:  Cancers (Basel)       Date:  2021-03-17       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.